DyonCRP® C-reactive protein
Using this product in 5 minutes and with 99% reliability you can:
- Confirm the presence of an infection
- Diagnose the severity of it by taking 3 different diagnostic values
- Diagnose between viruses and bacterial infections
Differential diagnosis of seasonal Influenza A/B & Covid19
FluCov2® is a rapid immunochromatography assay for the simultaneous qualitative detection of coronavirus antigen (SARS-CoV-2) and influenza A and type B virus antigens in human nasopharyngeal and pharyngeal swab samples for diagnosis of both coronavirus infection (SARS-CoV-2 COVID-19) and the diagnosis of influenza A and type B virus infection and their differential diagnosis.
DyonRota-Adeno® Rotavirus-Adenovirus
This product allows the medical professional to rapidly and accurately detect Rota virus – Adenovirus in stool samples of babies and children with gastroenteritis. Each virus is detected as a separate band.
DyonMono® Infectious Mononucleosis
By applying this product to human capillary blood you can diagnose infectious mononucleosis caused by Epstein Barr virus (EBV)
Specificity and sensitivity greater than 99%.
DyonStrepA-strip® Group A Streptococcus Antigen
By using a pharyngeal smear you can differentiate streptococcal infections from other biological markers with a sensitivity and specificity of 99%.
(http://www.cdc.gov/GETSMART/campaign-materials/info-sheets/adult-acute-pharyngitis.pdf)
(http://www.cdc.gov/getsmart/campaign-materials/info-sheets/adult-acute-pharyngitis.html)
DyoniFOB® Immunological Fecal Occult Blood
Microscopic examination of the presence of human hemoglobin in a faecal sample
- Specialty and Sensitivity: 99%
- Positive and negative predictive value greater than 97%
- The high level of reliability is due to the use of monoclonal antibodies
- There is no need for a special diet such as Mayer stools
Xeliac® Test Pro Anti- tTG IgA – IgG
DyonHpsA® H. pylori stool Ag
The first in the world to test helicobacter pylori antigen with specificity, sensitivity, positive and negative prognostic value that reaches 99% in histological comparison studies.
- Its reliability is not affected by the concomitant use of antecedent treatment
- The success of helicobacter eradication may be assessed whether or not within 2 weeks after the end of antibiotic treatment, and the patient continues to receive antisecretory treatment.